Find your next paid study

University of California, San FranciscoNCT06853223

~$75 – $1,800

Actual pay is set by the research site.

Phase 2

A Single-Arm Prospective Trial of Fluorescein Mapping in Patients Undergoing Vulvectomy for Extramammary Paget's Disease

The researchers are doing this study to see if giving people fluorescein sodium as an IV infusion before their vulvectomy for treating extramammary Paget's dis…

Extramammary Paget's Disease

Memorial Sloan Kettering Cancer CenterNCT06873815

~$75 – $2,000

Actual pay is set by the research site.

Couple-Based Meditation for Metastatic Lung Cancer Patients and Their Partners

Objectives: Our specific aims are to: Aim 1: Examine the feasibility of a couple-based meditation program in 50 patients with metastatic lung cancer and thei…

Lung Cancer

M.D. Anderson Cancer CenterNCT02596490

Actual pay is set by the research site.

Mild Traumatic Brain InjuryPost Traumatic Stress Disorder

Neuromodulation and Neurorehabilitation for Treatment of Functional Deficits After mTBI and PTSD

This study will determine (i) the magnitude of immediate and sustained effects of a current clinical standard interactive computer attention processing trainin…

Northwestern UniversityNCT03819608

Actual pay is set by the research site.

GriefGrief Disorder, ProlongedOverdose Accidental+1 more

Families Left Behind: Addressing Prolonged Grief and Substance Use Disorders Among People Bereaved by Drug Overdose Deaths

The United States is facing unprecedented rates of drug overdose deaths, profoundly impacting millions of families who are left to navigate their grief. Those …

Bilateral Vocal Cord Paralysis

~$10 – $1,125

Actual pay is set by the research site.

RANDNCT06854757

Selective Laryngeal Reinnervation for Bilateral Vocal Fold Paralysis

This is a prospective observational study examining the treatment outcomes of selective laryngeal reinnervation procedures for patients with bilateral vocal fo…

Weill Medical College of Cornell UniversityNCT03980275

Actual pay is set by the research site.

Phase 2

Pyridostigmine for the Treatment of Constipation in Parkinson Disease

Constipation is a common and debilitating non-motor symptom of Parkinson disease (PD) that often precedes the onset of classic motor symptoms by decades. There…

Parkinson DiseaseConstipation

University of Vermont Medical CenterNCT05603715

~$75 – $2,000

Actual pay is set by the research site.

Checkpoint InhibitorPilot StudyDiabetes Melletus

Checkpoint Inhibitor Associated Diabetes Mellitus: Early Recognition and Treatment (CERT) Project: A Pilot Study

To find out if taking a drug called infliximab (the "study drug") is safe and effective in reversing insulin dependence in CIADM.

M.D. Anderson Cancer CenterNCT07257068

Actual pay is set by the research site.

Phase 1

A Phase 1 Multicenter, Open-Label, Dose-Escalation and Expansion Study of NTB-928, a FRα-Targeting Bispecific T Cell Engager, in Subjects With Relapsed/Refractory Ovarian Carcinoma

The goal of this clinical trial is to determine if NTB-928 can be given safely to adult females with ovarian cancer that has come back (relapsed) or stopped re…

Relapsed/Refractory Ovarian Carcinoma

TeneoSeven, Inc.NCT07690189

~$150 – $4,200

Actual pay is set by the research site.

Peripheral Arterial Disease

Prehabilitation and Rehabilitation in PAD: A Randomized Exercise Intervention Trial (PREPARE-IT)

To determine the effectiveness of pre and post-operative exercise therapy in patients undergoing peripheral artery stenting for peripheral arterial disease.

Palo Alto Veterans Institute for ResearchNCT06566976

~$10 – $675

Actual pay is set by the research site.

Phase 2

Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response Via Modulation of ANdrogen Receptor (the SPIDERMAN Trial)

The objective of this study is to determine the safety and clinical effects of alternating pharmacologic (i.e. supraphysiologic) testosterone therapy with daro…

Metastatic Castration-resistant Prostate Cancer

Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT07142551

~$75 – $2,000

Actual pay is set by the research site.

Phase 1

A Phase 1/2, Multicentre, Open-label Clinical Trial of DT-7012 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Participants With Selected Advanced Solid Tumors (DOMISOL, DOmain_therapeutics Monoclonal antIbody for SOLid Tumors)

This is a phase 1/2, dose-escalation, clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of DT-7012 (an anti-…

Advanced Solid Tumors